Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis.
We have recently shown that non-viral gene therapy can stabilise the decline of lung function in patients with cystic fibrosis (CF). However, the effect was modest, and more potent gene transfer agents are still required. Fuson protein (F)/Hemagglutinin/Neuraminidase protein (HN)-pseudotyped lentivi...
Những tác giả chính: | Alton, E, Beekman, J, Boyd, A, Brand, J, Carlon, M, Connolly, M, Chan, M, Conlon, S, Davidson, H, Davies, J, Davies, L, Dekkers, J, Doherty, A, Gea-Sorli, S, Gill, D, Griesenbach, U, Hasegawa, M, Higgins, T, Hironaka, T, Hyndman, L, McLachlan, G, Inoue, M, Hyde, S, Innes, J, Maher, T, Moran, C, Meng, C, Paul-Smith, M, Pringle, I, Pytel, K, Rodriguez-Martinez, A, Schmidt, A, Stevenson, B, Sumner-Jones, S, Toshner, R, Tsugumine, S, Wasowicz, M, Zhu, J |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
BMJ Publishing Group
2016
|
Những quyển sách tương tự
-
Preparation for a first-in-man lentivirus trial in cystic fibrosis patients
Bằng: Griesenbach, U, et al.
Được phát hành: (2016) -
Moving lentiviral-based gene therapy into a first-in-man CF trial
Bằng: Griesenbach, D, et al.
Được phát hành: (2015) -
Towards a first-in-human trial with a pseudotyped lentivirus
Bằng: Alton, EW, et al.
Được phát hành: (2020) -
Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
Bằng: Hyde, S, et al.
Được phát hành: (2015) -
Assessment of F/HN-pseudotyped lentivirus as a clinically relevant vector for lung gene therapy.
Bằng: Griesenbach, U, et al.
Được phát hành: (2012)